BCL2 and cancer: However, Bcl-2 -938 C>A polymorphism was not significantly associated with cancer risk in Caucasians (dominant model: OR = 0.96, 95%CI: 0.79–1.16,P = 0.65; recessive model: OR = 1.04, 95%CI: 0.89–1.21, P = 0.82; allelic model: OR = 1.00, 95%CI: 0.89–1.12, P = 0.97; homozygote comparison: OR = 0.98, 95%CI:0.75–1.29, P = 0.91; heterozygote comparison: OR = 0.94, 95%CI:0.80–1.11, P = 0.48).